secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0000950170-25-089972
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Bio shareholders approve reverse split up to 1:250; Nevada reincorporation fails despite 89% support
--------------------------------------------------------------------------------

- Reverse stock split authorized at ratio 1:2 to 1:250, board to set exact ratio within one year.
- Issuance of common stock under May 2025 Class H Warrants above 20% exchange cap approved.
- Reincorporation from Delaware to Nevada failed (89% of votes cast in favor, but not enough outstanding shares).
- Lakhmir Chawla elected Class C director; advisory votes on exec compensation and frequency (3 years) passed.
- Baker Tilly US ratified as auditor for FY2025; CEO presentation given but details not disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017025089972/0000950170-25-089972-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017025089972/revb-20250623.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-089972

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer